Astria Therapeutics Inc (ATXS)
9.02
0.00 (0.00%)
USD |
NASDAQ |
May 28, 10:49
Astria Therapeutics Shareholders Equity (Quarterly): 367.74M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 367.74M |
| December 31, 2023 | 243.12M |
| September 30, 2023 | 184.48M |
| June 30, 2023 | 200.40M |
| March 31, 2023 | 211.36M |
| December 31, 2022 | 221.22M |
| September 30, 2022 | 112.87M |
| June 30, 2022 | 99.42M |
| March 31, 2022 | 109.69M |
| December 31, 2021 | 122.31M |
| September 30, 2021 | 130.43M |
| June 30, 2021 | 136.90M |
| March 31, 2021 | -101.14M |
| December 31, 2020 | 40.67M |
| September 30, 2020 | 49.31M |
| June 30, 2020 | 50.86M |
| March 31, 2020 | 53.71M |
| December 31, 2019 | 35.72M |
| September 30, 2019 | 38.27M |
| Date | Value |
|---|---|
| June 30, 2019 | 43.36M |
| March 31, 2019 | 49.87M |
| December 31, 2018 | 34.94M |
| September 30, 2018 | 40.52M |
| June 30, 2018 | 45.81M |
| March 31, 2018 | 12.93M |
| December 31, 2017 | 11.79M |
| September 30, 2017 | 15.66M |
| June 30, 2017 | 21.55M |
| March 31, 2017 | 23.96M |
| December 31, 2016 | 29.09M |
| September 30, 2016 | 36.86M |
| June 30, 2016 | 32.81M |
| March 31, 2016 | 41.72M |
| December 31, 2015 | 50.49M |
| September 30, 2015 | 59.54M |
| June 30, 2015 | 67.59M |
| March 31, 2015 | 13.49M |
| December 31, 2014 | -73.05M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-101.14M
Minimum
Mar 2021
367.74M
Maximum
Mar 2024
117.53M
Average
111.28M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 24.86M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 2.625M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 378.81M |
| Total Liabilities (Quarterly) | 11.07M |